Summary: ED&F Man Treasury Management plc Apr 02

  • ID: 1712335
  • April 2002
  • Standard & Poors
1 of 3

ED&F Man Treasury Management PLC, a corporation incorporated under the laws of the U.K. and a wholly owned subsidiary of ED&F Man Holdings Ltd., is authorized to issue up to $300 million in book-entry, discount commercial paper notes. The proceeds will be onlent or otherwise invested in the subsidiaries of ED&F Man Holdings Ltd. to be used by such subsidiaries in financing their assets and/or for other general corporate purposes. An irrevocable direct-pay LOC issued by Rabobank Nederland supports the payment of the notes at maturity....

Companies mentioned in this report are:
- Cooperatieve Rabobank U.A.

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.

Note: Product cover images may vary from those shown
2 of 3

- Cooperatieve Rabobank U.A.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.